Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation

The current treatment paradigm for atrial fibrillation (AF) prioritizes rate control over rhythm control; however, rhythm control has shown benefits over other AF strategies. This study compares the outcomes of rivaroxaban with and without concomitant antiarrhythmic drugs (AADs), using propensity sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiou, Wei-Ru, Lin, Po-Lin, Huang, Chun-Che, Chuang, Jen-Yu, Liu, Lawrence Yu-Min, Su, Min-I, Liao, Feng-Ching, Kuo, Jen-Yuan, Tsai, Cheng-Ting, Wu, Yih-Jer, Wang, Kuang-Te, Lee, Ying-Hsiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904581/
https://www.ncbi.nlm.nih.gov/pubmed/35260615
http://dx.doi.org/10.1038/s41598-022-07466-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904581/
https://www.ncbi.nlm.nih.gov/pubmed/35260615
http://dx.doi.org/10.1038/s41598-022-07466-z

Ejemplares similares